All filters
Slidesets
Hepatitis B Therapy Pipeline: How Far Are We From Cure- Peter Revill, PhD
Presented at:
APACC 2019
Slidesets
Epidemic of Acute HCV: What Have We Learned?- Chien-Ching Hung, MD, PhD
Presented at:
APACC 2019
Slidesets
Provider’s Perspective of PrEP Demedicalization- Heather-Marie Schmidt, BMedSc (Hon), MPH, PhD
Presented at:
APACC 2019
Slidesets
Community Perspective of Demedicalization of PrEP- Danvic Rosadiño
Presented at:
APACC 2019
Slidesets
Andrea De Luca Lecture: The top 10 important observations of the last year affecting clinical management- Ravindra Gupta, MD, PhD
Presented at:
European Meeting on HIV & Hepatitis 2019
Slidesets
How does the reservoir influence the clinician's decisions- Carlo Federico Perno, MD, PhD
Presented at:
European Meeting on HIV & Hepatitis 2019
Slidesets
Genetic Barrier – Clinical Cases- Roger Paredes, MD, PhD
Presented at:
European Meeting on HIV & Hepatitis 2019
Slidesets
New approaches to STI management- Gary Whitlock, MD
Presented at:
European Meeting on HIV & Hepatitis 2019
Slidesets
European surveillance of HIV drug resistance to NRTI, NNRTI and INSTI in newly diagnosed individuals using next-generation sequencing - Carole Seguin-Devaux
Presented at:
European Meeting on HIV & Hepatitis 2019
Slidesets
First results after 52 weeks of informal PrEP use in a cohort of MSM in Southern Spain - Manuel Reiriz Rojas
Presented at:
European Meeting on HIV & Hepatitis 2019
Slidesets
Seminal HIV-1 RNA and drug concentrations in DTG+3TC dual therapy (ANRS167 Lamidol)- Charlotte Charpentier
Presented at:
European Meeting on HIV & Hepatitis 2019
Slidesets
Predicting 2-drug antiretroviral regimen efficacy by genotypic susceptibility score: results from a cohort study- Barbara Rossetti
Presented at:
European Meeting on HIV & Hepatitis 2019
Slidesets
Molecular analysis suggests post-migration HIV-1 acquisition among migrants in Paris, France - Evangelia Kostaki
Presented at:
European Meeting on HIV & Hepatitis 2019
Slidesets
High prevalence of the integrase resistance associated accessory mutation L74I in the Russian Federation- Alina Kirichenko
Presented at:
European Meeting on HIV & Hepatitis 2019
Slidesets
Epidemiological study of Doravirine associated resistance mutations in HIV-1-infected antiretroviral-experienced patients from two large databases in France and Italy - Anne-Geneviéve Marcelin
Presented at:
European Meeting on HIV & Hepatitis 2019
Slidesets
Presentations from scientists from the industry- Luisa Stamm, MD, PhD
Presented at:
European Meeting on HIV & Hepatitis 2019
Slidesets
First line therapies: implications for long term resistance - Anne-Geneviève Marcelin, MD
Presented at:
European Meeting on HIV & Hepatitis 2019
Slidesets
Clinical case- Rocio Montejano Sanchez, MD
Presented at:
European Meeting on HIV & Hepatitis 2019
Slidesets
Specific NS5A polymorphisms correlate with hepatocellular carcinoma in cirrhotic patients infected with HCV genotype 1b - Mohammad Altkhatib
Presented at:
European Meeting on HIV & Hepatitis 2019
Slidesets
Novel markers on HBV / HDV co-infection - Valentina Svicher, PhD
Presented at:
European Meeting on HIV & Hepatitis 2019
Slidesets
The new patient - with what & when - Peter Reiss, MD, PhD
Presented at:
European Meeting on HIV & Hepatitis 2019
Slidesets
The aging patient - Eugenia Negredo, PhD
Presented at:
European Meeting on HIV & Hepatitis 2019
Slidesets
Longitudinal analysis of proviral HIV-DNA - Eva Heger
Presented at:
European Meeting on HIV & Hepatitis 2019